KYRYS Medical launched sterile-packed, single-use instrumentation for the SiJoin T5 posterior SI fusion implant, supporting delivery of a more efficient, predictable, and ASC-ready workflow.
The new T5 instrumentation offers:
Identical, procedure-ready instruments every time.
No sterilization delays, no missing components, no tray logistics.
Faster turnover, leaner operations, and predictable room flow.
The T5 SI Fusion System delivers immediate posterior stabilization, a minimally disruptive anatomical corridor, and an implant-only workflow with no supplemental hardware.
The sterile single-use instrumentation builds on a strong IP foundation, protecting key elements of posterior access, implant geometry, and workflow design. Rather than competing with multi-step systems, the T5 platform compounds its advantages through efficiency-driven, defendable innovation. “
“Competitors continue to rely on bulky trays, multi-step drill paths, and supplemental hardware,” said Terry Harvey, Co-CEO of KYRYS Medical. “The T5 eliminates those barriers, and sterile, single-use instrumentation pushes that efficiency even further.”
KYRYS Medical is the worldwide exclusive distribution arm for VGI Medical, commercializing the SiJoin T5 posterior SI fusion implant portfolio.
KYRYS Medical launched sterile-packed, single-use instrumentation for the SiJoin T5 posterior SI fusion implant, supporting delivery of a more efficient, predictable, and ASC-ready workflow.
The new T5 instrumentation offers:
Identical, procedure-ready instruments every time. No sterilization delays, no missing components, no tray...
KYRYS Medical launched sterile-packed, single-use instrumentation for the SiJoin T5 posterior SI fusion implant, supporting delivery of a more efficient, predictable, and ASC-ready workflow.
The new T5 instrumentation offers:
Identical, procedure-ready instruments every time.
No sterilization delays, no missing components, no tray logistics.
Faster turnover, leaner operations, and predictable room flow.
The T5 SI Fusion System delivers immediate posterior stabilization, a minimally disruptive anatomical corridor, and an implant-only workflow with no supplemental hardware.
The sterile single-use instrumentation builds on a strong IP foundation, protecting key elements of posterior access, implant geometry, and workflow design. Rather than competing with multi-step systems, the T5 platform compounds its advantages through efficiency-driven, defendable innovation. “
“Competitors continue to rely on bulky trays, multi-step drill paths, and supplemental hardware,” said Terry Harvey, Co-CEO of KYRYS Medical. “The T5 eliminates those barriers, and sterile, single-use instrumentation pushes that efficiency even further.”
KYRYS Medical is the worldwide exclusive distribution arm for VGI Medical, commercializing the SiJoin T5 posterior SI fusion implant portfolio.
Copy to clipboard 
